US: +1 630 333 9501 |
UK: +44 208 123 1770 |
Global Musculoskeletal Drugs Market 2011-2015
|
SKU: IRTNTR1194
Pages:
37 DescriptionDescription:
TechNavio's analysts forecast the Global Musculoskeletal Drugs market to grow at a CAGR of 14.4 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of musculoskeletal diseases. The Global Musculoskeletal Drugs market has also been witnessing the increasing use of drugs for treatment of multiple diseases. However, the upcoming patent expiries of top-selling drugs could pose a challenge to the growth of this market. TechNavio's report, the Global Musculoskeletal Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Musculoskeletal Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this market space include Abbott Laboratories Inc., Eli Lilly and Co., Johnson and Johnson Services Inc., and Pfizer Inc. Key questions answered in this report: You can request one free hour of analyst time when you purchase this report. Details provided within the report. TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market. Table of ContentsTable of Contents:
01. Executive Summary
02. Introduction 03. Market Coverage 04. Market Landscape 05. Geographical Segmentation 06. Key Leading Countries 07. Rate of Incidence and Prevalence 08. Vendor Landscape 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 15.1 Pfizer Inc. 15.2 Abbott Laboratories Inc. 15.3 Eli Lilly and Co. 15.4 Johnson & Johnson Services Inc. 16. Other Reports in this Series List of Exhibits: Exhibit 1: Global Musculoskeletal Drugs Market 2011-2015 (US$ billion) Exhibit 2: Global Musculoskeletal Drugs Market Segmentation by Drug Use 2011 Exhibit 3: Global Musculoskeletal Drugs market by Geographical Segmentation 2011 Exhibit 4: Global Musculoskeletal Drugs market by Vendor Segmentation 2011 |
Published May 21, 2012
Single User License: Allows one specific user access to the report Three User License: Allows up to three employees within your organization access to the report Five User License: Allows up to five employees within your organization access to the report Enterprise License: Allows all employees within your organization access to the report |